Regencell Bioscience (RGC.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow - Longbridge

Quote List Quote List

Event Tracking

Nov1

Regencell Bioscience released FY2025 annual earnings on October 31, 2025, EST: Actual Revenue USD 0, Actual EPS USD -0.0072

03:00

Regencell Bioscience released FY2025 Q3 earnings on October 31 (EST), actual revenue USD 0, actual EPS USD -0.0017

03:00

Regencell Bioscience released FY2025 9 Months earnings on October 31 (EST), actual revenue USD 0, actual EPS USD -0.0054

03:00

Regencell Bioscience released FY2025 Q4 earnings on October 31 (EST) with actual revenue of USD 0 and EPS of USD -0.0017

03:00

Jul15

Brain 再生科技 US stocks night session price down 3.27%

01:36

Jul7

Brain Regeneration Technology Soars Over 25% in Pre-Market

08:57

Schedules & Filings

Schedules

Filings

Oct31

Earning Release(EST)

FY2025 Q4 Earning Release (USD) Net Income -865.3 K, EPS -0.0017

Jun30

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -926.81 K, EPS -0.0018

Jun16

Stock Split(EST)

38-for-1 Stock Split

View More

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change

View More